AUDREY ONUZO: Open Payments
NPI 1598241614 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$231 in 13 payments from 9 companies in 2025. Trend: 2023 $140 · 2024 $16 · 2025 $231
Food & beverage: $231
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $47 |
| Astellas Pharma US Inc | 2 | $44 |
| Dexcom, Inc. | 2 | $33 |
| Novo Nordisk Inc | 2 | $31 |
| Amgen Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Merck Sharp & Dohme LLC | 1 | $16 |
| Xeris Pharmaceuticals, Inc. | 1 | $15 |
| Echosens North America, Inc. | 1 | $10 |
Products named: WATCHMAN Access System, Veozah, Dexcom G6 Transmitter, Wegovy, OTEZLA, AUSTEDO XR, GARDASIL 9, GVOKE HYPOPEN.
Industry payments across OH — which companies pay providers there.
